Heartsciences announces results and adjournment of annual shareholder meeting

Southlake, tx, jan. 18, 2024 (globe newswire) -- heart test laboratories, inc. d/b/a heartsciences (nasdaq: hscs; hscsw) ("heartsciences" or the "company"), an artificial intelligence (ai)-powered medical technology company focused on transforming ecgs/ekgs to save lives through earlier detection of heart disease, announced today the results of the company's 2024 annual meeting of shareholders (the “annual meeting”) as well as an adjournment of the annual meeting as outlined below.
HSCS Ratings Summary
HSCS Quant Ranking